22 Jul GENETHON
Imen Mestiri, Business Development and Licensing Lead
Oct. 5 | 9:30am | FLW Ballroom F
Évry-Courcouronnes, France
(Private)
A pioneer in the discovery and development of gene therapies for rare diseases, Genethon is a unique non-profit organization created by a patient association, the AFM- Telethon. Genethon has contributed to the development of the first gene therapy to receive market authorization for spinal muscular atrophy. With more than 200 scientists and professionals, Genethon continues to pursue its mission of delivering life-changing therapies to patients suffering from rare genetic diseases. Currently, Fifteen products resulting from Genethon’s research are in clinical trials for liver, blood, immune system, muscle and eye diseases. In addition, seven other products are in the preparation phase for clinical trials over the next five year.